Pei Hu Selected Research

Antibodies

4/2024	Characterizing Infections in Two Epidemic Waves of SARS-CoV-2 Omicron Variants: A Cohort Study in Guangzhou, China.
1/2022	Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis.
11/2021	An open-label, multiple-dose study to assess the preliminary pharmacokinetics, pharmacodynamics, clinical activity, and safety of human mouse chimeric anti-CD22 monoclonal antibody (SM03) in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei Hu Research Topics

Disease

27	Neoplasms (Cancer) 02/2024 - 07/2011
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 07/2011
8	Infections 04/2024 - 09/2015
8	Rheumatoid Arthritis 01/2022 - 01/2016
7	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2009
7	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2018
6	Sepsis (Septicemia) 01/2024 - 01/2017
6	Diarrhea 01/2023 - 08/2014
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 11/2016
5	Nausea 01/2023 - 08/2014
4	Body Weight (Weight, Body) 01/2024 - 07/2020
4	Hypoxia (Hypoxemia) 12/2023 - 01/2019
4	Osteoporosis 06/2021 - 05/2013
3	Exanthema (Rash) 01/2023 - 07/2009
3	Diabetes Mellitus 01/2021 - 01/2017
3	Liver Diseases (Liver Disease) 09/2019 - 11/2014
3	Hepatitis B 03/2018 - 09/2015
3	Ovarian Epithelial Carcinoma 03/2014 - 01/2013
2	Infarction (Infarctions) 04/2024 - 12/2008
2	Fibrosis (Cirrhosis) 01/2024 - 11/2014
2	Bone Fractures (Bone Fracture) 07/2023 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
2	Vomiting 01/2023 - 05/2021
2	Adenocarcinoma 01/2023 - 07/2011
2	Disease Progression 01/2022 - 07/2011
2	Hemorrhage 01/2022 - 07/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 06/2018
2	Inflammation (Inflammations) 10/2021 - 07/2019
2	Constipation 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 01/2010
2	Ischemic Stroke 08/2018 - 12/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2014
2	Measles 01/2018 - 06/2015
2	Headache (Headaches) 10/2016 - 07/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2016 - 06/2015
2	Dizziness (Lightheadedness) 02/2016 - 08/2014
2	Myalgia 02/2016 - 07/2009
2	Neoplasm Metastasis (Metastasis) 01/2014 - 03/2013
1	Reperfusion Injury 04/2024
1	Nervous System Diseases (Neurological Disorders) 04/2024
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2024
1	Reinfection 04/2024
1	Meningococcal Meningitis 03/2024
1	Myxoma (Myxomas) 02/2024

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2016
9	Tyrosine Kinase InhibitorsIBA 11/2022 - 07/2009
7	icotinibIBA 09/2015 - 07/2011
6	abivertinibIBA 01/2022 - 11/2016
6	ErbB Receptors (EGF Receptor)IBA 12/2018 - 07/2011
5	kukoamine BIBA 01/2024 - 01/2017
5	LipopolysaccharidesIBA 01/2024 - 03/2017
4	SodiumIBA 01/2024 - 07/2019
4	GlypicansIBA 12/2023 - 01/2018
4	Monoclonal AntibodiesIBA 01/2022 - 11/2016
3	Neuroprotective AgentsIBA 04/2024 - 12/2008
3	AntibodiesIBA 04/2024 - 11/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 09/2015
3	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 02/2017
3	imigliptinIBA 01/2021 - 08/2018
3	Liposomes (Liposome)IBA 01/2018 - 02/2013
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2013
3	VaccinesIBA 01/2018 - 06/2015
3	PlatinumIBA 03/2014 - 01/2013
2	AdiponectinIBA 07/2023 - 06/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2022
2	Anaplastic Lymphoma KinaseIBA 11/2022 - 05/2018
2	conteltinibIBA 11/2022 - 05/2018
2	EnzymesIBA 07/2022 - 01/2021
2	Palonosetron (Aloxi)FDA Link 05/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 09/2020 - 01/2019
2	Polysaccharides (Glycans)IBA 07/2020 - 12/2018
2	CholesterolIBA 07/2020 - 02/2013
2	BilirubinIBA 01/2020 - 07/2009
2	Leflunomide (Arava)FDA LinkGeneric 08/2019 - 07/2019
2	teriflunomideIBA 08/2019 - 07/2019
2	TabletsIBA 04/2019 - 11/2017
2	CurcuminIBA 01/2019 - 09/2017
2	CateninsIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2015
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2018 - 01/2009
2	Transaminases (Aminotransferases)IBA 01/2018 - 01/2018
2	Antiviral Agents (Antivirals)IBA 09/2017 - 11/2014
2	Gefitinib (Iressa)FDA Link 03/2016 - 03/2013
2	Cytochrome P-450 CYP2C19IBA 01/2014 - 12/2012
1	Insulin (Novolin)FDA Link 05/2024
1	snake venom protein C activatorIBA 05/2024
1	Proteolysis Targeting ChimeraIBA 05/2024
1	EdaravoneIBA 04/2024
1	Neutralizing AntibodiesIBA 04/2024
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 03/2024
1	AcidsIBA 02/2024

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2023 - 07/2011
5	Therapeutics 09/2023 - 07/2009
5	Oral Administration 08/2021 - 09/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 10/2016
2	Glycemic Control 07/2015 - 01/2009